Multiple Sclerosis Is On My Mind Initiative

Artist and patient Lydia Emily Archibald who is a spokesperson and creative director for MS On My Mind, an interactive initiative launched by EMD Serono, discusses her role in the project. She is joined by Dr. Daniel Bandari, M.D., M.S. founder of the Multiple Sclerosis Center of California, who discusses the physical challenges and prevalence associated with MS.

Read More

Chronic Kidney Disease (CKD) and The Next 5 Years

Anna Sundgren, Renal Disease Strategy Leader, Global Medicines Development at AstraZeneca, talks about what’s on the horizon for chronic kidney disease (CKD) patients, and the physicians that treat them — who’ve seen little innovation in treatment advancements in over 30 years.

Read More

Microvillus Inclusion Disease (MVID)

Dr. Dmitry Kravtsov, M.D., Vice President of Research & Development at Vanessa Research, Inc. (VRI), discusses the white paper “Addressing the Microvillus Inclusion Disease Knowledge Gap – A Comprehensive Case Analysis”.  MVID is a rare genetic disease that afflicts infants with very severe diarrhea. Shylicine™ is the first-ever drug developed to treat microvillus inclusion disease.  

Read More

Adhansia XR™ For ADHD

Andrew J. Cutler, MD, chief medical officer, Meridien Research, and an investigator on Adhansia XR™ (methylphenidate HCI) clinical studies, discusses the new FDA approval of Adlon Therapeutics Adhansia XR™ extended-release capsules Cll for the treatment of Attention-Deficit/Hyperactivity Disorder in patients 6 and older.  

Read More